Waters Co. (WAT) Shares Sold by Principal Financial Group Inc.
Principal Financial Group Inc. trimmed its holdings in shares of Waters Co. (NYSE:WAT) by 6.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 193,098 shares of the medical instruments supplier’s stock after selling 13,059 shares during the quarter. Principal Financial Group Inc. owned 0.24% of Waters worth $34,665,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in WAT. OppenheimerFunds Inc. lifted its position in shares of Waters by 2.0% during the first quarter. OppenheimerFunds Inc. now owns 1,750 shares of the medical instruments supplier’s stock worth $274,000 after purchasing an additional 35 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Waters by 1.6% during the first quarter. Dimensional Fund Advisors LP now owns 207,633 shares of the medical instruments supplier’s stock worth $32,455,000 after purchasing an additional 3,187 shares during the last quarter. Atria Investments LLC bought a new stake in shares of Waters during the second quarter worth $202,000. Bank of Montreal Can lifted its position in shares of Waters by 7.2% during the second quarter. Bank of Montreal Can now owns 68,663 shares of the medical instruments supplier’s stock worth $12,622,000 after purchasing an additional 4,623 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. lifted its position in shares of Waters by 1,019.2% during the second quarter. NN Investment Partners Holdings N.V. now owns 5,529 shares of the medical instruments supplier’s stock worth $1,017,000 after purchasing an additional 5,035 shares during the last quarter. Institutional investors and hedge funds own 91.82% of the company’s stock.
Waters Co. (NYSE:WAT) opened at $198.21 on Friday. Waters Co. has a 52 week low of $133.35 and a 52 week high of $199.83. The company has a quick ratio of 5.71, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $15,870.00, a PE ratio of 27.17, a price-to-earnings-growth ratio of 2.84 and a beta of 0.82.
Waters (NYSE:WAT) last posted its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.03. Waters had a return on equity of 21.21% and a net margin of 24.06%. The company had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. During the same quarter in the previous year, the firm earned $1.57 earnings per share. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. equities research analysts expect that Waters Co. will post 7.42 EPS for the current fiscal year.
Several analysts have recently weighed in on the company. The Goldman Sachs Group, Inc. assumed coverage on Waters in a research report on Tuesday, September 26th. They set a “hold” rating and a $180.00 target price for the company. Barclays PLC lifted their target price on Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 25th. BidaskClub upgraded Waters from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, August 16th. Zacks Investment Research upgraded Waters from a “hold” rating to a “buy” rating and set a $211.00 target price for the company in a research report on Monday, October 23rd. Finally, Morgan Stanley reiterated an “underweight” rating and set a $192.00 target price (up from $183.00) on shares of Waters in a research report on Friday, October 6th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Waters currently has a consensus rating of “Hold” and a consensus price target of $193.62.
In other Waters news, SVP Elizabeth B. Rae sold 12,000 shares of Waters stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $197.95, for a total value of $2,375,400.00. Following the transaction, the senior vice president now owns 18,129 shares in the company, valued at $3,588,635.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Rohit Khanna sold 18,400 shares of Waters stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $185.78, for a total value of $3,418,352.00. Following the completion of the transaction, the senior vice president now owns 22,477 shares in the company, valued at approximately $4,175,777.06. The disclosure for this sale can be found here. Insiders sold 57,313 shares of company stock worth $11,120,642 in the last quarter. 5.07% of the stock is owned by insiders.
COPYRIGHT VIOLATION NOTICE: This report was published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.watchlistnews.com/waters-co-wat-shares-sold-by-principal-financial-group-inc/1711596.html.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.